查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1528976

陰莖植入物市場規模 - 按植入物類型（充氣式、非充氣式）、材料（矽膠、Bioflex）、最終用途（醫院、門診手術中心）和全球預測，2024 - 2032 年

Penile Implants Market Size - By Implant Type (Inflatable, Non-inflatable), Material (Silicone, Bioflex), End-use (Hospitals, Ambulatory Surgical Centres) & Global Forecast, 2024 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 150 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

由於全球勃起功能障礙 (ED) 盛行率不斷上升，預計 2024 年至 2032 年間，陰莖假體市場規模的複合年成長率將達到 4.7%。據報道，預計到 2025 年，勃起功能障礙將影響全球 3.22 億男性。 ED 負擔日益加重可能是由多種因素造成的，包括老化、心血管疾病、糖尿病、高血壓以及吸煙和飲酒等生活方式的選擇。隨著全球人口老化和這些健康狀況的發病率不斷增加，對有效 ED 治療（包括陰莖植入物）的需求將相應增加。

新興經濟體不斷成長的醫療基礎設施以及不斷增加的醫療支出正在推動市場擴張。消除 ED 污名化和促進有關性健康的公開討論的轉變正在鼓勵更多男性尋求治療。隨著越來越多的人獲得醫療保健服務，預計 ED 的診斷和治療率將會上升，導致產品需求增加。

陰莖植入物產業按植入物類型、材料、最終用途和地區進行分類。

根據植入物類型，由於與充氣植入物相比，非充氣植入物簡單、可靠且易於使用，預計到 2032 年，非充氣植入物市場規模將大幅成長。非充氣陰莖植入物提供簡單的外科手術，機械故障的風險較低。這些植入物也為性活動提供持續的準備狀態，同時消除了對複雜充氣機制的需求。

由於這些設施提供的效率、便利性和成本效益，預計到 2032 年，門診手術中心領域的陰莖植入物市場將錄得較高的收入佔有率。門診手術中心 (ASC) 提供專業的門診手術護理，使患者能夠在比傳統醫院更不那麼令人生畏、對患者更友好的環境中接受陰莖植入手術。這些設定還可以縮短手術時間、減少住院時間並降低整體醫療費用。

在醫療保健意識不斷提高、可支配收入增加以及導致勃起功能障礙的生活方式疾病日益流行的推動下，亞太地區陰莖植入物行業規模將在 2032 年大幅成長。不斷擴大的中產階級人口變得更加注重健康，並願意投資先進的醫療手段。快速的城市化和生活方式的改變進一步導致糖尿病、高血壓和其他與 ED 相關疾病的發病率升高，從而促進了區域市場的成長。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 勃起功能障礙的發生率上升
      • 技術進步
      • 慢性病盛行率不斷上升
    • 產業陷阱與挑戰
      • 與手術相關的高成本
      • 存在替代藥物治療
  • 成長潛力分析
  • 技術景觀
  • 監管環境
  • 未來市場趨勢
  • 波特的分析
  • PESTEL分析

第 4 章：競爭格局

  • 介紹
  • 公司市佔率分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 戰略展望矩陣

第 5 章：市場估計與預測：按植入物類型，2021 - 2032 年

  • 主要趨勢
  • 充氣的
  • 非充氣式

第 6 章：市場估計與預測：按材料分類，2021 - 2032 年

  • 主要趨勢
  • 矽酮
  • 百福萊克斯
  • 其他材料

第 7 章：市場估計與預測：按最終用途，2021 - 2032 年

  • 主要趨勢
  • 醫院
  • 門診手術中心
  • 其他最終用戶

第 8 章：市場估計與預測：按地區，2021 - 2032

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區

第 9 章：公司簡介

  • Boston Scientific Corporation
  • Coloplast Corp
  • Dornier MedTech
  • Eska Medical Gmbh
  • Giant Medical LLC
  • GT Urological, LLC
  • Owen Mumford Ltd.
  • Pos-T-Vac, Inc.
  • Promedon
  • Reflexonic LLC
  • Rigicon Inc.
  • Silimed
  • Sofregen Medical Inc.
  • Uroplasty Inc.
  • Zephyr Surgical Implants
簡介目錄
Product Code: 9426

Penile implants market size is projected to witness a 4.7% CAGR between 2024 and 2032 driven by the rising prevalence of erectile dysfunction (ED) globally. As per reports, it is projected that by 2025, erectile dysfunction will affect 322 million men worldwide. This growing burden of ED can result from various factors including aging, cardiovascular diseases, diabetes, hypertension, and lifestyle choices, such as smoking and alcohol consumption. With the aging global population and the increasing incidence of these health conditions, the demand for effective ED treatments, including penile implants, will rise correspondingly.

The growing healthcare infrastructure in emerging economies, coupled with increasing healthcare expenditure are fueling the market expansion. The shift towards destigmatizing ED and promoting open discussions about sexual health is encouraging more men to seek treatment. As more individuals are gaining access to healthcare services, the diagnosis and treatment rates of ED are expected to rise, leading to higher product demand.

The penile implants industry is classified into implant type, material, end-use and region.

Based on implant type, the market size from the non-inflatable segment is projected to witness substantial growth through 2032 due to simplicity, reliability, and ease of use compared to inflatable implants. Non-inflatable penile implants offer a straightforward surgical procedure with a lower risk of mechanical failure. These implants also provide a constant state of readiness for sexual activity while eliminating the need for complex inflation mechanisms.

Penile implants market from the ambulatory surgical centers segment is predicted to record a high revenue share by 2032 owing to the efficiency, convenience, and cost-effectiveness offered by these facilities. Ambulatory surgical centers (ASCs) provide specialized, outpatient surgical care, allowing patients to undergo penile implant procedures in a less intimidating, more patient-friendly environment compared to traditional hospitals. These settings also offer results in shorter procedure times, reduced hospital stays, and lower overall healthcare costs.

Asia Pacific penile implants industry size will grow significantly through 2032 driven by rising healthcare awareness, increasing disposable incomes, and the growing prevalence of lifestyle diseases leading to erectile dysfunction. The expanding middle-class population is becoming more health-conscious and willing to invest in advanced medical treatments. Rapid urbanization, and changing lifestyles are further contributing to the higher incidences of diabetes, hypertension, and other conditions associated with ED, adding to the regional market growth.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising incidence of erectile dysfunction
      • 3.2.1.2 Technological advancement
      • 3.2.1.3 Growing prevalence of chronic diseases
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost associated with the procedure
      • 3.2.2.2 Presence of alternative drug treatment
  • 3.3 Growth potential analysis
  • 3.4 Technological landscape
  • 3.5 Regulatory landscape
  • 3.6 Future market trends
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Implant Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Inflatable
  • 5.3 Non-inflatable

Chapter 6 Market Estimates and Forecast, By Material, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Silicone
  • 6.3 Bioflex
  • 6.4 Other materials

Chapter 7 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Ambulatory surgical centres
  • 7.4 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Netherlands
    • 8.3.7 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Rest of Latin America
  • 8.6 Middle East and Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 South Africa
    • 8.6.3 UAE
    • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

  • 9.1 Boston Scientific Corporation
  • 9.2 Coloplast Corp
  • 9.3 Dornier MedTech
  • 9.4 Eska Medical Gmbh
  • 9.5 Giant Medical LLC
  • 9.6 GT Urological, LLC
  • 9.7 Owen Mumford Ltd.
  • 9.8 Pos-T-Vac, Inc.
  • 9.9 Promedon
  • 9.10 Reflexonic LLC
  • 9.11 Rigicon Inc.
  • 9.12 Silimed
  • 9.13 Sofregen Medical Inc.
  • 9.14 Uroplasty Inc.
  • 9.15 Zephyr Surgical Implants